Article info
PDFClinical and epidemiological research
Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss
- P P Tak, Division of Clinical Immunology and Rheumatology, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; P.P.Tak{at}amc.uva.nl
Citation
Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss
Publication history
- Accepted March 31, 2008
- First published April 13, 2008.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Wijbrandts et al 2009 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.